Tag: pharmaceutical company in usa

January 16, 2019

Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health

Pain Therapeutics (Nasdaq:PTIE), a clinical-stage drug development company, announced it has been awarded $1.5 million in research funding from the...
January 3, 2019

Verrica Achieves Positive Topline Results from Two Pivotal Phase 3 Clinical Trials of VP-102

Verrica Pharmaceuticals (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin...
January 2, 2019

Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate

Innovation Pharmaceuticals (OTCQB:IPIX) a clinical stage pharmaceutical company, reported today that the U.S. Patent & Trademark Office recently announced the...
January 2, 2019

Acer Therapeutics Announces In-license of Osanetant from Sanofi

Acer Therapeutics (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening...
December 31, 2018

Innovus Pharmaceuticals Announces $3.17 Million Private Placement

Innovus Pharmaceuticals (OTCQB:INNV) an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products...
December 24, 2018

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that its most...
December 20, 2018

Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD

Supernus Pharmaceuticals (NASDAQ:SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases,...